StrategyInsightsAbout usConnect with us →
Professional investors only

This section contains marketing communications for professional and qualified investors.

By continuing, you confirm that you qualify as a professional investor under applicable EU regulations and are resident in a jurisdiction where this content is permitted to be made available to you.

If you do not qualify, please return to the homepage.

A specialist European growth-credit platform.

GrowthPath Investments is a specialist European growth-credit platform originating senior-secured term loans at €1–3M to Late-Seed and Series A B2B technology companies. The strategy targets a structurally underserved segment in European private credit. The defining characteristic of our segment: structurally underserved, systematically addressable, and historically resilient.

This page contains marketing communications intended for professional and qualified investors only. By accessing this content, you confirm you qualify as a professional investor under applicable EU regulations.

Legal & Disclaimers →

Historical evolution of European Growth Debt

Structural changes in fund sizes pushed providers upmarket.

2005–2014
Early Growth Debt
Fund Size€50M – €150M
Ticket Size€1M – €3M
StageSeed / Series A

Debt used as runway extension. Smaller funds optimised for small tickets.

2015–2019
VC Market Expansion
Fund Size€150M – €400M
Ticket Size€3M – €8M
StageSeries A+ / B

VC rounds grew significantly. Debt funds scaled alongside and shifted to Series B.

2020–2025
Institutional Growth Debt
Fund Size€500M – €1.25B+
Ticket Size€10M – €30M+
StageSeries B+ / pre-IPO

Mega VC funds, platform lenders, institutional LPs. Blackrock / Kreos VII: €1.25B.

The €1–3M ticket segment that historically existed has largely disappeared as funds scaled and moved upmarket.

The borrower universe behind each segment

Swipe to compare segments
Mid
€3–15M Tickets
Typical Company Profile
StageSeries A / Series B
Revenue€5–20M; growth 30–80% YoY
EBITDANegative to near-breakeven (–50% to +5%)
Equity Raised€10–40M total
Team30–100 FTEs; institutional board
Investors1–2 international VCs
Deal Characteristics
Facility Size€3–15M
StructureTerm loan ± RBF ± revolver
Maturity36–48 months
PricingOID + 8–15% cash + 8–15% warrants
Use of ProceedsGrowth capex, M&A bridge, runway
Risk & Market Size

Growth stall / funding gap risk. Most competitive segment. Standard covenants & IP protection.

€4–6Bdeployed annually (EU)
Large
€15–50M Tickets
Typical Company Profile
StageSeries B / C / pre-IPO
Revenue€20–50M; growth 20–50% YoY
EBITDANegative to near-breakeven (–50% to +5%)
Equity Raised€40–150M+ total
Team100–300 FTEs; CFO / full C-suite
InvestorsLarge syndicate of VC / CVC funds
Deal Characteristics
Facility Size€15–50M
StructureTerm loan ± delayed draw ± revolver
Maturity36–60 months
PricingOID + EURIBOR + 500–750bps cash + 4–5% warrants
Use of ProceedsScale-up, international expansion
Risk & Market Size

Lower credit risk; near-investment grade quality. Competitive with banks & less active alternative lenders.

€8–10Bdeployed annually (EU)

Why growth debt is structurally resilient

A senior-secured, income-oriented category. This describes the growth-debt asset class, not a specific GrowthPath product.

Senior-secured, first-lien position

Lenders rank ahead of equity and subordinated creditors. Structure reduces loss severity. It does not remove the risk of loss.

Contracted interest income

Returns are driven primarily by contractual loan interest rather than equity appreciation, an income-oriented profile.

Warrant coverage

Facilities are typically structured with warrants, adding return potential alongside contracted interest.

2.6% historical category loss rate

Observed across the European growth-debt category over 20+ years.
Source: Preqin, Pitchbook. Past performance does not predict future results.

How the security works

Each facility is secured against the borrower’s assets, including intellectual property, contracts, and receivables.

In a default scenario, the lender holds a first-priority claim, ranking ahead of equity and subordinated creditors in the recovery of capital.

Tested across market cycles

Growth debt as a category has operated through the dot-com correction, the 2008 financial crisis, and the COVID period.

Request the market thesis

Research and commentary from the GrowthPath team. Independent analysis on European growth credit. No sponsored content. Available to professional and qualified investors upon self-certification.

Request access

We do not share your contact information. We respond to all requests within 2 business days.

Request received.

We will review your request and send the market thesis to the email address provided within 2 business days.

Notes and analyses on this page are research commentary intended for general informational and educational purposes. They do not constitute investment advice, a recommendation, or an offer to sell any security or fund interest. Information about GrowthPath's investment strategy is made available to professional and qualified investors upon self-certification.